Trials / Unknown
UnknownNCT05151458
Serum NGAL as a Predictor of Clinical and Endoscopic Activity of Inflammatory Bowel Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Accepted
Summary
Ulcerative colitis (UC) and Crohns disease (CD) represent the two major forms of inflammatory bowel disease (IBD), characterized by epithelial cell damage and prominent mucosal infiltration by inflammatory cells including granulocytes, macrophages, lymphocytes, and plasma cells.
Conditions
Timeline
- Start date
- 2021-12-29
- Primary completion
- 2022-11-29
- Completion
- 2022-11-30
- First posted
- 2021-12-09
- Last updated
- 2021-12-14
Source: ClinicalTrials.gov record NCT05151458. Inclusion in this directory is not an endorsement.